Making good decisions in the drug discovery process requires software to effectively manage the size and complexity of multiparametric datasets. Companies that most quickly and accurately identify key drug discovery parameters will win the race to identify the most appropriate targets and develop medicines to affect them.
PerkinElmer has produced a free to download whitepaper which takes a look at:
- The requirements for high throughput screening, high content screening and surface plasmon resonance
- Makes suggestions for how best to streamline
- How to make these processes more flexible and repeatable
Download the whitepaper here